On March 8, 2021 vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, reported its participation in the H.C. Wainwright Global Life Sciences Conference held virtually March 9-10, 2021 (Press release, vTv Therapeutics, MAR 8, 2021, View Source [SID1234576333]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will be providing a general company update through a virtual presentation that will be available on demand for conference attendees beginning on March 9, 2021. Company management will also be meeting with members of the investment community during one-on-one virtual meetings.